![2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2,4-oxadiazol-5-yl]propanoyl]amino]cyclohexene-1-carboxylic acid in PDB entry 8ihf, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/8ihf_entity_7_side_image-200x200.png "Hetero pentameric assembly 1 of PDB entry <span class='highlight'>8ihf</span> contains 1 copy of <span class='highlight'>2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2,4-oxadiazol-5-yl]propanoyl]amino]cyclohexene-1-carboxylic acid</span>. Side view.")
![2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2,4-oxadiazol-5-yl]propanoyl]amino]cyclohexene-1-carboxylic acid in PDB entry 8ihf, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/8ihf_entity_7_top_image-200x200.png "Hetero pentameric assembly 1 of PDB entry <span class='highlight'>8ihf</span> contains 1 copy of <span class='highlight'>2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2,4-oxadiazol-5-yl]propanoyl]amino]cyclohexene-1-carboxylic acid</span>. Top view.")
Environment details NEW
FI7 602 bound to chain R
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.